SCHEMBL21031310

SCHEMBL21031310

c1ccc(-c2ccc(-c3cc(-c4ccc(-c5c6ccccc6nc6oc7ccccc7c56)cc4)nc(-c4ccccc4)n3)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HPGD P15428 7/20 0.42
▸ MEN1 O00255 6/20 0.42
▸ KMT2A Q03164 6/20 0.42
▸ ALDH1A1 P00352 6/20 0.42
▸ MAPT P10636 6/20 0.42
▸ NTSR1 P30989 1/20 0.42
▸ DHODH Q02127 1/20 0.40
▸ LMNA P02545 5/20 0.39
▸ SMN1; SMN2 Q16637 2/20 0.39
▸ ACHE P22303 1/20 0.38
▸ KDM4E B2RXH2 5/20 0.38
▸ GLA P06280 1/20 0.38
▸ BRD4 O60885 1/20 0.38
▸ ESR1 P03372 2/20 0.38
▸ ESR2 Q92731 2/20 0.38
▸ CDK1 P06493 2/20 0.38
▸ CCNB1 P14635 2/20 0.38
▸ CCNE1 P24864 2/20 0.38
▸ CDK2 P24941 2/20 0.38
▸ CCNE2 O96020 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21031309 1.00 HPGD (0.42) HPGDMEN1KMT2AALDH1A1MAPT
SCHEMBL21031251 0.99 HPGD (0.43) HPGDMEN1KMT2AALDH1A1MAPT
SCHEMBL21030667 0.95 HPGD (0.40) HPGDMEN1KMT2AALDH1A1MAPT
SCHEMBL21032445 0.95 HPGD (0.40) HPGDMEN1KMT2AALDH1A1MAPT
SCHEMBL21031304 0.95 MEN1 (0.42) HPGDMEN1KMT2AALDH1A1MAPT
SCHEMBL21031471 0.94 HPGD (0.41) HPGDMEN1KMT2AALDH1A1MAPT
SCHEMBL21031474 0.93 HPGD (0.39) HPGDMEN1KMT2AALDH1A1MAPT
SCHEMBL21031303 0.92 MEN1 (0.41) HPGDMEN1KMT2AALDH1A1MAPT
SCHEMBL21030665 0.92 MEN1 (0.41) HPGDMEN1KMT2AALDH1A1MAPT
SCHEMBL21031308 0.92 MEN1 (0.41) HPGDMEN1KMT2AALDH1A1MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes IDEMITSU KOSAN CO., LTD. (JP) 2023-07-04 — — US disclosed
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES IDEMITSU KOSAN CO., LTD. (JP) 2019-05-30 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11691983-B2 Specifically substituted benzofuro- and benzothienoquinolines for organic light emitting diodes KCNQ2, KCNQ1, KCNQ4 HPGD 2093/4885MEN1 3802/4885KMT2A 1221/4885
US-20190161497-A1 SPECIFICALLY SUBSTITUTED BENZOFURO- AND BENZOTHIENOQUINOLINES FOR ORGANIC LIGHT EMITTING DIODES KCNQ2, KCNQ1, KCNQ4 HPGD 2093/4885MEN1 3802/4885KMT2A 1221/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback